Abstracts tagged "self-management and systemic lupus erythematosus (SLE)"

Abstract Number: 2680 • 2018 ACR/ARHP Annual Meeting
Activation Towards Health Self-Management in Patients with Systemic Lupus Erythematosus
Paul R. Fortin¹, Carolyn Neville², Anne-Sophie Julien³, Murray Rochon⁴, Davy Eng⁵, Christine A. Peschken⁶, Evelyne Vinet⁷, Marie Hudson⁸, Doug Smith⁹, Mark Matsos¹⁰, Janet E. Pope¹¹, Ann E. Clarke¹², Stephanie Keeling¹³, J. Antonio Avina-Zubieta¹⁴ and Deborah Da Costa¹⁵, ¹Medicine, CHU de Québec - Université Laval, Québec, QC, Canada, ²Department of Medicine, McGill University Health Center, Montreal, QC, Canada, ³CHU de Québec - Université Laval, Quebec City, QC, Canada, ⁴Jack Digital, Toronto, ON, Canada, ⁵Centre de recherche du CHU de Québec - Université Laval - Axe maladies infectieuses et immunitaires, CHU de Québec - Université Laval, Quebec, QC, Canada, ⁶RR 149G, University of Manitoba, Winnipeg, MB, Canada, ⁷Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁸Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada, ⁹Division of Rheumatology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, ¹⁰Medicine, McMaster University, Hamilton, ON, Canada, ¹¹Department of Medicine, University of Western Ontario, London, ON, Canada, ¹²Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ¹³Department of Medicine, University of Alberta, University of Alberta, Edmonton, AB, Canada, ¹⁴Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁵Medicine, McGill University, Montreal, QC, Canada
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with fluctuating levels of disease activity. Control of disease activity is associated with better outcomes…
Abstract Number: 790 • 2015 ACR/ARHP Annual Meeting
An Intervention to Improve Quality of Life for African-American Lupus Patients
Edith M. Williams¹, Johnese Bostic², Alyssa Adkins³, Larisa Bruner², Jiajia Zhang², Diane L. Kamen⁴ and Jim Oates⁴, ¹Institute for Partnerships to Eliminate Health Disparities, University of South Carolina, Columbia, SC, ²University of South Carolina, Columbia, SC, ³University of South Carolina, Greenville, SC, ⁴Medicine, Medical University of South Carolina, Charleston, SC
Background/Purpose: The Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN) Project is designed to examine whether a uniquely tailored intervention program can…
Abstract Number: 2695 • 2012 ACR/ARHP Annual Meeting
Benefits of the Chronic Disease Self-Management Program in Low-Income African American Women with Systemic Lupus Erythematosus: Results of a Pilot Test
Cristina Drenkard¹, Charmayne M. Dunlop-Thomas², Kirk Easley³, Gaobin Bao⁴, S. Sam Lim⁵ and Teresa J. Brady⁶, ¹Medicine, Div Rheumatology, Emory University, Atlanta, GA, ²Medicine Rheumatology, Emory University, Atlanta, GA, ³Emory University, Atlanta, GA, ⁴Medicine, Emory University, Atlanta, GA, ⁵Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁶Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Minorities with systemic lupus erythematosus (SLE) are at high risk of poor disease outcomes and may face challenges in effectively self-managing multiple health problems.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].